2021-01-11,"Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day"
2021-01-11,Blueprint Medicines Announces R&D Leadership Transitions
2021-01-11,Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine Leadership
2021-01-08,3 Biotech Stocks Worth Adding to Your Portfolio in 2021
2021-01-05,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2021-01-04,Axsome's (AXSM) Migraine Drug Shows Long-Term Safety in Study
2020-12-31,Amarin (AMRN) Surges: Stock Moves 9% Higher
2020-12-30,Is Blueprint Medicines Corporation's (NASDAQ:BPMC) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
2020-12-22,Is BPMC A Good Stock To Buy According To Hedge Funds?
2020-12-21,Blueprint Medicines (BPMC) Rises 40% in Past 3 Months: Here's Why
2020-12-17,Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
2020-12-07,Blueprint Medicines Data Presented at 62nd ASH Annual Meeting and Exposition Highlight Broad Commitment to Advance Patient Care in Systemic Mastocytosis
2020-12-04,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-12-02,Blueprint Medicines' (BPMC) Gavreto Approved for Thyroid Cancer
2020-12-01,Blueprint Medicines Announces FDA Approval of GAVRETO (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
2020-11-23,Blueprint Medicines To Present Broad Range of Data Reinforcing Commitment to Advance Patient Care in Systemic Mastocytosis at 62nd ASH Annual Meeting and Exposition
2020-11-03,Was The Smart Money Right About Loading Up On Blueprint Medicines Corporation (BPMC)?
2020-11-03,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-11-01,Blueprint Medicines Corporation (NASDAQ:BPMC) Just Beat EPS By 19%: Here's What Analysts Are Forecasting For Next Year
2020-10-30,"The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts"
2020-10-29,"Blueprint Medicines (BPMC) Q3 Earnings Beat, Revenues Rise Y/Y"
2020-10-29,Blueprint Medicines (BPMC) Q3 Earnings and Revenues Surpass Estimates
2020-10-29,Blueprint Medicines: Q3 Earnings Insights
2020-10-29,Blueprint Medicines Reports Third Quarter 2020 Financial Results
2020-10-29,Blueprint Medicines Corp. to Host Earnings Call
2020-10-26,5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
2020-10-22,"Blueprint Medicines to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020"
2020-10-02,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-09-30,Imagine Holding Blueprint Medicines (NASDAQ:BPMC) Shares While The Price Zoomed 333% Higher
2020-09-29,Blueprint Medicines Rises YTD on Robust Ayvakit Progress
2020-09-28,Blueprint Medicines' Gist Drug Ayvakyt Gets EU Approval
2020-09-25,Blueprint Medicines Announces European Commission Approval of AYVAKYTÂ® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
2020-09-23,Blueprint Medicines Up on Positive Top-Line Data From SM Study
2020-09-23,"Company News for Sep 23, 2020"
2020-09-23,"The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma"
2020-09-22,Blueprint Medicines Reports Positive Test Results For Rare Disease Treatment; BPMC Stock Jumps
2020-09-22,Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT (avapritinib) in Patients with Advanced Systemic Mastocytosis
2020-09-20,Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer
2020-09-17,Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
2020-09-13,Is Blueprint Medicines a Good Biotech Stock to Buy Now?
2020-09-09,Blueprint Medicines (BPMC): Hedge Fund Sentiment Reaches Another All Time High
2020-09-09,Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare Conference
2020-09-04,Blueprint Medicines Announces FDA Approval of GAVRETO (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
2020-09-04,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-09-01,"Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development"
2020-08-29,Why Is Blueprint Medicines (BPMC) Up 0.1% Since Last Earnings Report?
2020-08-04,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-08-01,Blueprint Medicines (NASDAQ:BPMC) Is In A Strong Position To Grow Its Business
2020-07-31,"Blueprint Medicines' (BPMC) Q2 Earnings Miss, Revenues Beat"
2020-07-30,"Blueprint Medicines (BPMC) Reports Q2 Loss, Tops Revenue Estimates"
2020-07-30,Recap: Blueprint Medicines Q2 Earnings
2020-07-30,Blueprint Medicines Reports Second Quarter 2020 Financial Results
2020-07-24,Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
2020-07-23,"Blueprint Medicines to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020"
2020-07-14,Could A $775 Million Roche-Blueprint Deal Unseat Eli Lilly In Cancer?
2020-07-14,Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
2020-07-14,"Blueprint Medicines, Roche to Develop Pralsetinib for Cancer"
2020-07-14,Blueprint Medicines shares gain on deal with Roche
2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits"
2020-07-14,We're Not Very Worried About Blueprint Medicines' (NASDAQ:BPMC) Cash Burn Rate
2020-07-14,Roche gene testing key to $1.7 billion deal for Blueprint cancer drug
2020-07-14,Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers
2020-07-13,Did Hedge Funds Make The Right Call On Blueprint Medicines Corporation (BPMC) ?
2020-07-02,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-07-02,Blueprint Medicines Files NDA to FDA for Pralsetinib in MTC
2020-07-01,Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers
2020-06-29,Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST
2020-06-06,Blueprint Medicines Presents Updated Part 1 Data from PIONEER Trial of Avapritinib Showing Robust Reductions in Cutaneous Disease Symptoms in Patients with Indolent Systemic Mastocytosis
2020-06-05,Blueprint Medicines (BPMC) Up 15.5% Since Last Earnings Report: Can It Continue?
2020-06-03,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2020-06-03,The Debate Is Over: This Cancer Stock Is Winning the GIST Race
2020-06-03,Hedge Funds Are Done Buying Blueprint Medicines Corporation (BPMC)
2020-05-29,8 Stocks Viking Global Investors Continues to Buy
2020-05-29,"Blueprint Medicines Announces Data Presentations at ASCO20 Highlighting Deep, Durable Clinical Activity and Well-Tolerated Safety Profile of Pralsetinib Across Broad Range of RET Fusion-Positive Tumors"
2020-05-27,Blueprint Medicines to Present at Upcoming Investors Conferences
2020-05-26,"Blueprint Medicines to Host Conference Call to Review Updated Clinical Data for Pralsetinib in RET-Altered Cancers on Friday, May 29, 2020"
2020-05-18,Blueprint Medicines Gets CRL for Ayvakit in Fourth-Line Gist
2020-05-15,U.S. FDA declines to approve Blueprint's therapy for type of stomach cancer
2020-05-15,Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
2020-05-14,Edited Transcript of BPMC earnings conference call or presentation 6-May-20 12:30pm GMT
2020-05-14,All You Need to Know About Blueprint Medicines (BPMC) Rating Upgrade to Buy
2020-05-14,Blueprint Medicines Announces Data Presentations Highlighting Significant Progress in Advancing RET-Altered Cancer and Systemic Mastocytosis Programs
2020-05-12,How Blueprint Medicines (BPMC) Stock Stands Out in a Strong Industry
2020-05-07,"Blueprint Medicines (BPMC) Q1 Earnings Top, Revenues Soar Y/Y"
2020-05-07,Blueprint Medicines (BPMC) Q1 2020 Earnings Call Transcript
2020-05-06,"Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates"
2020-05-06,Blueprint Medicines Reports First Quarter 2020 Financial Results
2020-04-28,Blueprint Medicines Tumbles 20.8% on Phase 3 Study Failure
2020-04-28,P/E Ratio Insights for Blueprint Medicines
2020-04-28,Blueprint Medicines Announces Top-line Results from Phase 3 VOYAGER Trial of Avapritinib versus Regorafenib in Patients with Advanced Gastrointestinal Stromal Tumor
2020-04-16,Should You Be Concerned About Blueprint Medicines Corporation's (NASDAQ:BPMC) Historical Volatility?
2020-04-09,Blueprint Medicines (BPMC) Upgraded to Buy: Here's Why
2020-04-01,Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
2020-03-27,Hedge Funds Have Never Been This Bullish On Blueprint Medicines Corporation (BPMC)
2020-03-16,"Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis"
2020-03-14,Why Is Blueprint Medicines (BPMC) Down 21.6% Since Last Earnings Report?
2020-03-09,"Blueprint Medicines to Report Updated Data from the Phase 2 PIONEER Trial of Avapritinib in Indolent Systemic Mastocytosis on Monday, March 16, 2020"
2020-03-06,5 Biotech Stocks to Buy for a Strong Growth Prognosis
2020-02-20,Edited Transcript of BPMC earnings conference call or presentation 13-Feb-20 1:30pm GMT
2020-02-19,3 Strong Buy Healthcare Stocks With Fast-Approaching Catalysts
